Literature DB >> 28938053

Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana.

Nana-Kwadwo Biritwum1, Paul Yikpotey2, Benjamin K Marfo1, Samuel Odoom1, Ernest O Mensah2, Odame Asiedu1, Bright Alomatu1, Edward T Hervie1, Abednego Yeboah1, Serge Ade3,4, Sven G Hinderaker5, Anthony Reid6, Kudakwashe C Takarinda4, Benjamin Koudou7, Joseph B Koroma2.   

Abstract

Background: Among the 216 districts in Ghana, 98 were declared endemic for lymphatic filariasis in 1999 after mapping. Pursuing the goal of elimination, WHO recommends annual treatment using mass drugs administration (MDA) for at least 5 years. MDA was started in the country in 2001 and reached national coverage in 2006. By 2014, 69 districts had 'stopped-MDA' (after passing the transmission assessment survey) while 29 others remained with persistent microfilaraemia (mf) prevalence (≥1%) despite more than 11 years of MDA and were classified as 'hotspots'.
Methods: An ecological study was carried out to compare baseline mf prevalence and anti-microfilaria interventions between hotspot and stopped-MDA districts.
Results: Baseline mf prevalence was significantly higher in hotspots than stopped-MDA districts (p<0.001). After three years of MDA, there was a significant decrease in mf prevalence in hotspot districts, but it was still higher than in stopped-MDA districts. The number of MDA rounds was slightly higher in hotspot districts (p<0.001), but there were no differences in coverage of MDA or long-lasting-insecticide-treated nets. Conclusions: The main difference in hotspots and stopped-MDA districts was a high baseline mf prevalence. This finding indicates that the recommended 5-6 rounds annual treatment may not achieve interruption of transmission.
© The Author 2017. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ghana; Hotspots; Lymphatic filariasis; MDA; Mass drug administration

Mesh:

Substances:

Year:  2016        PMID: 28938053     DOI: 10.1093/trstmh/trx007

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  20 in total

1.  Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.

Authors:  Collins S K Ahorlu; Eric Koka; Susan Adu-Amankwah; Joseph Otchere; Dziedzom Komi de Souza
Journal:  BMC Public Health       Date:  2018-02-13       Impact factor: 3.295

2.  Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration.

Authors:  Yahya A Derua; William N Kisinza; Paul E Simonsen
Journal:  Parasit Vectors       Date:  2018-07-20       Impact factor: 3.876

3.  Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.

Authors:  Colleen L Lau; Sarah Sheridan; Stephanie Ryan; Maureen Roineau; Athena Andreosso; Saipale Fuimaono; Joseph Tufa; Patricia M Graves
Journal:  PLoS Negl Trop Dis       Date:  2017-09-18

4.  Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.

Authors:  Dziedzom K de Souza; Katherine Gass; Joseph Otchere; Ye Min Htet; Odame Asiedu; Benjamin Marfo; Nana-Kwadwo Biritwum; Daniel A Boakye; Collins S Ahorlu
Journal:  PLoS Negl Trop Dis       Date:  2020-05-14

5.  Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.

Authors:  Sellase Pi-Bansa; Joseph Harold Nyarko Osei; Kwadwo Kyeremeh Frempong; Elizabeth Elhassan; Osei Kweku Akuoko; David Agyemang; Collins Ahorlu; Maxwell Alexander Appawu; Benjamin Guibehi Koudou; Michael David Wilson; Dziedzom Komi de Souza; Samuel Kweku Dadzie; Jürg Utzinger; Daniel Adjei Boakye
Journal:  Infect Dis Poverty       Date:  2019-02-05       Impact factor: 4.520

6.  Ghana: Accelerating neglected tropical disease control in a setting of economic development.

Authors:  Peter J Hotez; Nana-Kwadwo Biritwum; Alan Fenwick; David H Molyneux; Jeffrey D Sachs
Journal:  PLoS Negl Trop Dis       Date:  2019-01-17

7.  Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?

Authors:  Chandana H Mallawarachchi; T G A Nilmini Chandrasena; Ranjan Premaratna; S M N S M Mallawarachchi; Nilanthi R de Silva
Journal:  Parasit Vectors       Date:  2018-01-29       Impact factor: 3.876

8.  Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.

Authors:  Dziedzom K de Souza; Collins S Ahorlu; Susan Adu-Amankwah; Joseph Otchere; Sedzro K Mensah; Irene A Larbi; George E Mensah; Nana-Kwadwo Biritwum; Daniel A Boakye
Journal:  Trials       Date:  2017-10-02       Impact factor: 2.279

9.  Progress on elimination of lymphatic filariasis in Sierra Leone.

Authors:  Joseph B Koroma; Santigie Sesay; Abdul Conteh; Jusufu Paye; Mohamed Bah; Mustapha Sonnie; Mary H Hodges; Yaobi Zhang
Journal:  Parasit Vectors       Date:  2018-06-04       Impact factor: 3.876

10.  Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.

Authors:  Andres Garchitorena; Estelle M Raza-Fanomezanjanahary; Sedera A Mioramalala; Cédric B Chesnais; Claude A Ratsimbasoa; Herinirina Ramarosata; Matthew H Bonds; Holivololona Rabenantoandro
Journal:  PLoS Negl Trop Dis       Date:  2018-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.